Paracetamol, also known as acetaminophen, is a medication used to treat pain and fever. It is typically used for mild to moderate pain relief. Evidence is mixed for its use to relieve fever in children. It is often sold in combination with other medications, such as in many cold medications. Paracetamol is also used for severe pain, such as cancer pain and pain after surgery, in combination with opioid pain medication. It is typically used either by mouth or rectally, but is also available by injection into a vein. Effects last between two and four hours.
Paracetamol was first made in 1877. It is the most commonly used medication for pain and fever in both the United States and Europe. It is on the World Health Organization's List of Essential Medicines. Paracetamol is available as a generic medication, with brand names including Tylenol and Panadol among others. In 2017, it was the 25th-most commonly prescribed medication in the United States, with more than 24 million prescriptions.
Market Analysis and Insights: Global and Japan Paracetamol Active Pharmaceutical Ingredients Market
This report focuses on global and Japan Paracetamol Active Pharmaceutical Ingredients market.
In 2020, the global Paracetamol Active Pharmaceutical Ingredients market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Paracetamol Active Pharmaceutical Ingredients market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Paracetamol Active Pharmaceutical Ingredients Scope and Market Size
Paracetamol Active Pharmaceutical Ingredients market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Paracetamol Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Paracetamol Active Pharmaceutical Ingredients market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.
Segment by Type
Purity (99%-99.5%)
Purity (above 99.5%)
Purity (below 99 %)
Segment by Application
Headache and Fever
Cold and Cough
Muscle Cramps
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Mallinckrodt Pharmaceuticals
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Paracetamol was first made in 1877. It is the most commonly used medication for pain and fever in both the United States and Europe. It is on the World Health Organization's List of Essential Medicines. Paracetamol is available as a generic medication, with brand names including Tylenol and Panadol among others. In 2017, it was the 25th-most commonly prescribed medication in the United States, with more than 24 million prescriptions.
Market Analysis and Insights: Global and Japan Paracetamol Active Pharmaceutical Ingredients Market
This report focuses on global and Japan Paracetamol Active Pharmaceutical Ingredients market.
In 2020, the global Paracetamol Active Pharmaceutical Ingredients market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Paracetamol Active Pharmaceutical Ingredients market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Paracetamol Active Pharmaceutical Ingredients Scope and Market Size
Paracetamol Active Pharmaceutical Ingredients market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Paracetamol Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Paracetamol Active Pharmaceutical Ingredients market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.
Segment by Type
Purity (99%-99.5%)
Purity (above 99.5%)
Purity (below 99 %)
Segment by Application
Headache and Fever
Cold and Cough
Muscle Cramps
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Mallinckrodt Pharmaceuticals
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.